Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,640.10
+7.10 (0.43%)
At close: Oct 28, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 946.38 billion as of October 28, 2026. Its market cap has increased by 48.85% in one year.
Market Cap
946.38B
Enterprise Value
921.18B
Revenue
349.35B
Global Rank
n/a
Country Rank
n/a
PE Ratio
25.63
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 946.38B, an increase of 9,754.78%. That is a compound annual growth rate of 20.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 946.38B | 37.74% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.40T |
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 1.11T |
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |